Edition:
United Kingdom

Mizuho Medy Co Ltd (4595.T)

4595.T on Tokyo Stock Exchange

6,140JPY
7:00am BST
Change (% chg)

¥110 (+1.82%)
Prev Close
¥6,030
Open
¥6,060
Day's High
¥6,150
Day's Low
¥5,970
Volume
24,200
Avg. Vol
45,593
52-wk High
¥6,830
52-wk Low
¥2,130

Chart for

About

Mizuho Medy Co Ltd is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly operates its businesses through one segment: In-vitro Diagnostic Pharmaceuticals segment. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): ¥28,767.31
Shares Outstanding(Mil.): 4.76
Dividend: --
Yield (%): 0.70

Financials

  4595.T Industry Sector
P/E (TTM): 43.58 35.24 32.21
EPS (TTM): 138.59 -- --
ROI: 22.27 14.18 13.05
ROE: 30.46 16.92 14.90

BRIEF-Mizuho Medy obtains marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination

* Says it obtained the marketing and manufacture approval of mycoplasma nucleic acid kit for genetic POCT examination in Japan on Feb. 19

22 Feb 2018

BRIEF- Mizuho Medy to acquire property for 282.8 mln yen

* Says it plans to acquire Fukuoka-based land for 282.8 million yen

22 Dec 2017

Earnings vs. Estimates